European Commission Approves Ionis and Otsuka’s Da...
Category : Approval/Launch 27 January 2026Ionis Pharmaceuticals and Otsuka Pharmaceutical have received European Commission approval for Dawnz...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Novo Medi Sciences Launches Nexipox Plus, India-Sp...
Category : Approval/Launch 27 January 2026Novo Medi Sciences Pvt. Ltd. has launched Nexipox Plus, a next-generation varicella (chickenpox) vac...
Sanofi’s Amlitelimab Delivers Positive Phase 3 Dat...
Category : Clinical Trial Update 27 January 2026Sanofi announced positive results from two global Phase 3 trials of amlitelimab in adolescents and a...
Gillson Sciences Expands into Environmental Health...
Category : Licensing/Collaboration Deal 23 January 2026Gillson Sciences has announced the acquisition of SanAir Technologies Laboratory, Inc., an accredite...
AGC Biologics Supports Commercial Launch of Waskyr...
Category : Approval/Launch 23 January 2026AGC Biologics’ Milan Cell and Gene Center of Excellence will continue supporting the commercia...
Latest Newsletter Post
-
Sanofi’s Amlitelimab Delivers Posit..
27 January 2026
-
Novo Medi Sciences Launches Nexipox..
27 January 2026
-
European Commission Approves Ionis..
27 January 2026
-
Trevi Therapeutics’ Nalbuphine ER S..
23 January 2026
-
HistoIndex Partners with Houston Re..
23 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com